The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Anti-Inflammatory Drugs Market Across 2026–2030?
The anti-inflammatory drugs market size has experienced significant growth over recent years. The market is anticipated to increase from $152.08 billion in 2025 to $168.74 billion in 2026, with a compound annual growth rate (CAGR) of 11.0%. Factors contributing to its historical growth include arthritis prevalence, nsaid usage, hospital prescribing, autoimmune disease burden, and steroid therapy adoption.
The anti-inflammatory drugs market is projected for substantial expansion in the coming years, reaching a valuation of $252.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period is driven by factors such as advancements in biologics, increased penetration of biosimilars, an expanding aging population, a rise in autoimmune diseases, and the adoption of precision medicine. Key trends expected over the forecast horizon encompass the expanding application of biologics and biosimilars, broader treatment options for chronic inflammatory conditions, a move towards more targeted anti-inflammatory treatments, an increase in topical and localized drug formulations, and a heightened emphasis on long-term safety considerations.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp
What Primary Drivers Are Shaping The Development Of The Anti-Inflammatory Drugs Market?
The increasing prevalence of arthritis is anticipated to propel the expansion of the anti-inflammatory drugs market moving forward. Arthritis is defined as the inflammation of one or more joints, resulting in pain, swelling, and stiffness that can worsen with advancing age. The heightened occurrence of arthritis is primarily due to aging populations; as individuals grow older, the natural wear and tear on their joints intensifies, leading to a greater likelihood of developing arthritis. Anti-inflammatory drugs assist in managing arthritis by diminishing joint inflammation and pain, enabling patients to sustain better mobility and perform daily activities with enhanced ease, ultimately elevating their overall quality of life. For example, in July 2024, according to Restored CDC, a US-based nonprofit health information body, approximately 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Consequently, the rising prevalence of arthritis is fueling the growth of the anti-inflammatory drugs market.
What Segmentation Levels Are Considered In The Anti-Inflammatory Drugs Market?
The anti-inflammatory drugs market covered in this report is segmented –
1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes
2) By Route of Administration: Parenteral, Oral, Topical, Inhalation
3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Steroids: Corticosteroids, Mineralocorticoids
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors
3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars
4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
What Trends Are Projected To Affect The Anti-Inflammatory Drugs Market?
Leading firms operating in the anti-inflammatory drugs market are concentrating on creating novel solutions, including advanced corticosteroid alternatives, to satisfy the growing need for safer anti-inflammatory treatments over extended periods. Such next-generation corticosteroid alternatives are therapies designed to maintain glucocorticoid anti-inflammatory efficacy while minimizing common side effects of conventional steroids, such as bone density loss, stunted growth, and increased weight. As an illustration, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, secured US FDA approval for AGAMREE (vamorolone) in October 2023. AGAMREE is an oral dissociative steroid crafted to provide anti-inflammatory action with fewer steroid-associated adverse effects by selectively influencing glucocorticoid receptor pathways and stabilizing cellular membranes. It presents a superior safety profile compared to conventional corticosteroids such as prednisone and deflazacort, while still delivering therapeutic advantages. This medication is prescribed for managing chronic muscle inflammation in children aged two years and older who have Duchenne muscular dystrophy.
Which Leading Firms Are Contributing To The Growth Of The Anti-Inflammatory Drugs Market?
Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited
Read the full anti-inflammatory drugs market report here:
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report
How Does The Anti-Inflammatory Drugs Market Perform Across Major Global Regions?
North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Anti-Inflammatory Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp
Browse Through More Reports Similar to the Global Anti-Inflammatory Drugs Market 2026, By The Business Research Company
Rheumatology Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Rare Inflammatory Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model